e-learning
resources
Virtual 2020
Pre-Congress Content
Inhaled corticosteroids and bronchodilator studies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adherence to 6-month FDC Budesonide/Formoterol treatment and Quality of Life in Greek asthmatic patients-COMPLETE study
N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), A. Papataxiarchou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece)
Source:
Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Session:
Inhaled corticosteroids and bronchodilator studies in asthma
Session type:
E-poster session
Number:
2639
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), A. Papataxiarchou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece). Adherence to 6-month FDC Budesonide/Formoterol treatment and Quality of Life in Greek asthmatic patients-COMPLETE study. 2639
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Source: International Congress 2016 – Asthma management
Year: 2016
Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Primary care physician assessment of COPD severity: European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Comparison of demographic data of patients with COPD treated in primary care by country in European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL)
Source: Eur Respir J 2001; 17: 52-58
Year: 2001
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire
Source: Eur Respir J 2003; 22: 127-134
Year: 2003
Validation of the Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) in young Argentinean children
Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Year: 2018
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Adherence to FDC Budesonide/Formoterol treatment and lung function of Greek asthmatic patients–COMPLETE study
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Correlating patient characteristics and adherence to their severe asthma inhaler regimen, and assessment of the Medication Adherence Report Scale
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept